Nearly three decades after first discovering the tumor-suppressing Par-4 “super gene” that has been shown to kill cancer cells, a team of researchers at the University of Kentucky Markey Cancer Center is now learning about its role in preventing obesity.
This blog is written by B. Mark Evers, M.D., director of the University of Kentucky Markey Cancer Center, in recognition of National Cancer Research Month.
The UK Markey Cancer Center joins Caris' extensive network of leading cancer institutions committed to utilizing clinical data to advance patient care and outcomes.
There is evidence that liquid biopsies obtained from a blood sample have the potential to replace tumor biopsies requiring patients to undergo a surgical procedure.
The University of Kentucky Markey Cancer Center Foundation received a $1 million gift to create the world’s first distinguished professorship in neuroendocrine tumor (NET) research.
Junior Lauren Hudson’s passion for research started her freshman year, when Nathan Vanderford, the assistant director for research in the UK Markey Cancer Center, reached out to her about participating in his research program.
In this episode of Behind the Blue, Evers takes us through some of the most important milestones and accomplishments of the Markey team during his time at UK, and discusses plans for Markey’s future.
University of Kentucky and UK HealthCare experts will be featured in a three-part series by Kentucky Educational TV (KET) that examines the causes, impact and new developments in the treatment of lung disease in Kentucky.
UK HealthCare announced a historic $10 million gift from Central Bank to support expanded patient care at Markey Cancer Center, the largest in UK HealthCare history.
